These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1344303)

  • 41. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion.
    Yoshida D; Ikeda Y; Nakazawa S
    Neurol Med Chir (Tokyo); 1995 Mar; 35(3):133-5. PubMed ID: 7770105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
    Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
    J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration.
    Iwadate Y; Namba H; Tagawa M; Takenaga K; Sueyoshi K; Sakiyama S
    Oncology; 1997; 54(4):329-34. PubMed ID: 9216859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model.
    Yoshida D; Ikeda Y; Nakazawa S
    Neurosurgery; 1995 Aug; 37(2):287-92; discussion 292-3. PubMed ID: 7477781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells.
    Takai N; Tanaka R; Yoshida S; Hara N; Saito T
    Cancer Res; 1988 Apr; 48(8):2047-52. PubMed ID: 3258182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
    Holladay FP; Heitz T; Wood GW
    J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
    Cool V; Pirotte B; Gérard C; Dargent JL; Baudson N; Levivier M; Goldman S; Hildebrand J; Brotchi J; Velu T
    Hum Gene Ther; 1996 Mar; 7(5):627-35. PubMed ID: 8845388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.
    Tapscott SJ; Miller AD; Olson JM; Berger MS; Groudine M; Spence AM
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8185-9. PubMed ID: 8058777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors.
    Kruse CA; Schiltz PM; Bellgrau D; Kong Q; Kleinschmidt-DeMasters BK
    J Neurooncol; 1994; 19(2):161-8. PubMed ID: 7964992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapy.
    Namba H; Iwadate Y; Iyo M; Fukushi K; Irie T; Sueyoshi K; Tagawa M; Sakiyama S
    Nucl Med Biol; 1998 Apr; 25(3):247-50. PubMed ID: 9620630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fractionated radiosurgery for 9L gliosarcoma in the rat brain.
    Kim JH; Khil MS; Kolozsvary A; Gutierrez JA; Brown SL
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1035-40. PubMed ID: 10571213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide.
    Manome Y; Wen PY; Chen L; Tanaka T; Dong Y; Yamazoe M; Hirshowitz A; Kufe DW; Fine HA
    Gene Ther; 1996 Jun; 3(6):513-20. PubMed ID: 8789801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
    Rainov NG; Dobberstein KU; Heidecke V; Dorant U; Chase M; Kramm CM; Chiocca EA; Breakefield XO
    Cancer Gene Ther; 1998; 5(3):158-62. PubMed ID: 9622099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine.
    Yoshida D; Ikeda Y; Nakazawa S
    J Neurooncol; 1993 Aug; 17(2):91-7. PubMed ID: 8145063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
    Chen L; Waxman DJ
    Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of human melanoma hepatic metastases in nude mice with human cytotoxic T lymphocytes.
    Crowley NJ; Vervaert CE; Seigler HF
    Arch Surg; 1991 Apr; 126(4):433-7. PubMed ID: 2009057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.